DRG Market Assessment reports
Access comprehensive market intelligence covering Disease Landscape & Forecast, Epidemiology Intelligence, Biosimilars Intelligence, China In-depth and more.
Primary Biliary Cholangitis | Treatment Algorithms: Claims Data Analysis | US | 2022
Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by inflammation, progressive damage, and, ultimately, destruction of the interlobular bile ducts; this process is…
Major Depressive Disorder | Treatment Algorithms: Claims Data Analysis | US | 2022
Major depressive disorder (MDD) is a highly drug-treated condition that utilizes an array of drug classes, including selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine…
Crohn’s Disease | Treatment Algorithms: Claims Data Analysis | Adult | US | 2022
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by diarrhea, abdominal pain, and weight loss. The primary goal of CD treatment is to induce and…
Atopic Dermatitis | Emerging Therapies | Eucrisa (crisaborole) | US | Wave 2 | 2017
Atopic Dermatitis | Emerging Therapies | Eucrisa | US is a three-wave series that tracks the introduction of Pfizer’s Eucrisa for the treatment of AD. The series is based on primary research data…
Male Hypogonadism (Low Testosterone) | Niche & Rare Disease Landscape & Forecast | US/EU5
Male hypogonadism is characterized by low serum testosterone and impaired spermatogenesis. Primary male hypogonadism results from an intrinsic abnormality in the testes, while secondary male…
Essential Thrombocythemia | Treatment Algorithms: Claims Data Analysis | US | 2022
Essential thrombocythemia (ET) is a rare chronic myeloproliferative disease characterized by the overproduction of platelets. While the etiology of ET is not fully understood, a genetic mutation…
